回首頁 到查詢結果 [ subject:"Pharmaceutical policy" ]

Impact of TRIPS in India[electronic ...
Malhotra, Prabodh, (1951-)

 

  • Impact of TRIPS in India[electronic resource] :an access to medicines perspective /
  • 紀錄類型: 書目-語言資料,印刷品 : Monograph/item
    杜威分類號: 338.4/761510954
    書名/作者: Impact of TRIPS in India : an access to medicines perspective // Prabodh Malhotra.
    作者: Malhotra, Prabodh,
    出版者: Basingstoke, Hampshire ; : Palgrave Macmillan,, 2010.
    面頁冊數: 1 online resource (xxi, 320 p.) : : ill.
    標題: Pharmaceutical industry - India.
    標題: Pharmaceutical policy - India.
    標題: Health services accessibility - India.
    標題: Drug Industry - India.
    標題: Health Services Accessibility - India.
    標題: International Cooperation - India.
    標題: Patents as Topic - legislation & jurisprudence - India.
    標題: (1994)
    標題: Agreement on Trade-Related Aspects of Intellectual Property Rights.
    標題: Health services accessibility.
    標題: India.
    標題: Pharmaceutical industry.
    標題: Pharmaceutical policy.
    標題: BUSINESS & ECONOMICS - Industries
    ISBN: 9780230290747 (electronic bk.)
    ISBN: 0230290744 (electronic bk.)
    書目註: Includes bibliographical references and index.
    內容註: Foreword -- Acknowledgments -- Introduction -- PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES -- The World Trade Organization and the TRIPS Agreement -- The Global Pharmaceutical Industry and Developing New Drugs -- PART II: ACCESS TO MEDICINES IN INDIA -- Development of India's Pharmaceutical Industry -- TRIPS and the Indian Patents Regime -- Price Controls and Drug Affordability in India: Policy Options -- Health Insurance in India -- Broadening the Access to Medicines and Healthcare in India -- PART III: GLOBAL PERSPECTIVE -- Is TRIPS Appropriate for Developing Countries? -- Which Way Ahead? -- Final Conclusions -- References.
    摘要、提要註: Over the last three decades, drug prices in India have declined from one of the highest to one of the lowest in the world. Yet, under the current healthcare model, only around 35 per cent of people in India have access to medicines. In the lead up to 2005, when TRIPS compliant regime was introduced in India, there were apprehensions about the drug prices rising under the new regime, which would further restrict access to medicine. This book examines the impact of TRIPS on drug prices and exports of drugs and pharmaceuticals in India. It goes on to develop a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable, and can be replicated in other developing countries. This book is indispensable reading for all interested in development economics, intellectual property rights in developing countries, pharmaceutical markets and health systems.
    電子資源: An electronic book accessible through the World Wide Web; click for information
Export
取書館別
 
 
變更密碼
登入